Optimal drug and behavior therapy for treatment-refractory schizophrenic patients.

Liberman, R P; Van Putten, T; Marshall, B D; Mintz, J; Bowen, L; Kuehnel, T G; Aravagiri, M; Marder, S R

Liberman, R P; Van Putten, T; Marshall, B D; Mintz, J; Bowen, L; Kuehnel, T G; Aravagiri, M; Marder, S R.

Afiliación

Liberman RP; Camarillo-UCLA Research Center, Camarillo State Hospital, CA 93011-6022.

Am J Psychiatry ; 151(5): 756-9, 1994 May.

Article en En | MEDLINE | ID: mdl-8166320

RESUMEN

Thirteen treatment-refractory schizophrenic patients (10 men and three women) who were receiving more than 50 mg/day of haloperidol and who had been hospitalized for more than 1 year successfully tolerated a mean dose reduction of 63% with consequent improvement in psychopathology and side effects. The addition of intensive behavior therapy to the optimal dose of haloperidol yielded further improvements in functional behavior, such as self-care and social interaction.

Asunto(s)

Terapia Conductista; Haloperidol/uso terapéutico; Esquizofrenia/terapia; Adulto; Terapia Combinada; Relación Dosis-Respuesta a Droga; Esquema de Medicación; Femenino; Haloperidol/administración & dosificación; Hospitalización; Humanos; Relaciones Interpersonales; Masculino; Esquizofrenia/tratamiento farmacológico; Psicología del Esquizofrénico; Autocuidado

Buscar en Google

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Esquizofrenia / Terapia Conductista / Haloperidol Límite: Adult / Female / Humans / Male Idioma: En Revista: Am J Psychiatry Año: 1994 Tipo del documento: Article Pais de publicación: Estados Unidos

Buscar en Google

Añadir a Mi BVS

Imprimir

XML

PubMed Links